In this exclusive interview Jay Johnson, DGSA, Regulatory Compliance from Inmark, and Chairman of the Dangerous Goods Advisory Council (DGAC) Board of Directors, speaks to Andrea Charles from Cold Chain IQ, about new initiatives at the DGAC, the key challenges of shipping dangerous biologics and shares his top tip for successful secure and efficient intermodal transportation of biologics. Johnson also highlights the difficulties biologic manufacturers face in navigating evolving biologic transport regulations, greater harmonisation between regulations and the most common violations.
What is the weakest link in cold chain supply? Will cloud computing revolutionize the biopharmaceutical supply chain? In this interview Carlos Castro Global Transportation and Logistics, Bayer Healthcare and Andrea Charles from Cold Chain IQ, discuss the importance of quality biologistics, key regulatory and operation considerations for cold chain supply and future trends in the global pharmaceutical logistics.
In this interview Meserve Platt, Associate Director Materials / Facilities, Crescendo Bioscience, Inc., speaks to Andrea Charles from Cold Chain IQ, about finding the right partners to improve service levels, managing reverse logistics and 3rd party partnerships and collaborations. Platt also shares his future outlook on the diagnostic landscape.